Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells.
Cieniewicz B, Uyeda MJ, Chen PP, Sayitoglu EC, Liu JM, Andolfi G, Greenthal K, Bertaina A, Gregori S, Bacchetta R, Lacayo NJ, Cepika AM, Roncarolo MG.
Cieniewicz B, et al.
Haematologica. 2021 Oct 1;106(10):2588-2597. doi: 10.3324/haematol.2020.263129.
Haematologica. 2021.
PMID: 33054128
Free PMC article.